Cargando…

Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond

Detalles Bibliográficos
Autores principales:	Kar, Sumit, Islam, Rafiqul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Newlands Press Ltd 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255425/ https://www.ncbi.nlm.nih.gov/pubmed/32453605 http://dx.doi.org/10.4155/bio-2020-0116

Ejemplares similares

COVID-19’s impact on bioanalytical labs
por: Lavelle, Amy, et al.
Publicado: (2021)

An alternative approach for bioanalytical assay optimization for wastewater-based epidemiology of SARS-CoV-2
por: Boogaerts, Tim, et al.
Publicado: (2021)

Bioanalytical research and training in academia during the COVID-19 pandemic
por: Klont, Frank, et al.
Publicado: (2020)

Managing bioanalytical studies during the COVID-19 pandemic: an overview
por: Pruim, Peter, et al.
Publicado: (2020)

Safety considerations in the bioanalytical laboratories handling specimens from coronavirus disease 2019 patients
por: Chen, Zhuo, et al.
Publicado: (2020)

Moving vaccination beyond partisan politics
por: Hoffman, Beth L., et al.
Publicado: (2022)

Bioanalytical Assay Strategies and Considerations for Measuring Cellular Kinetics
por: Hays, Amanda, et al.
Publicado: (2022)

Development of a highly sensitive bioanalytical assay for the quantification of favipiravir.
por: Curley, Paul, et al.
Publicado: (2021)

Pharmacokinetic Characterization and Tissue Distribution of Fusion Protein Therapeutics by Orthogonal Bioanalytical Assays and Minimal PBPK Modeling
por: Sugimoto, Hiroshi, et al.
Publicado: (2020)

Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies?
por: Bowsher, Ronald R., et al.
Publicado: (2020)

Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis
por: Kar, Sumit, et al.
Publicado: (2019)

SARS-CoV-2 diagnostics: Some reflections on current assays
por: Antonelli, Guido, et al.
Publicado: (2021)

Avidity assay to test functionality of anti-SARS-Cov-2 antibodies
por: Gaspar, Emanuelle Baldo, et al.
Publicado: (2021)

Bioanalytical Methods in Toxicology
por: Skrzydlewska, Elżbieta
Publicado: (2008)

Emerging Bioanalytical Devices and Platforms for Rapid Detection of Pathogens in Environmental Samples
por: Ngashangva, Lightson, et al.
Publicado: (2022)

A Compact Control System to Enable Automated Operation of Microfluidic Bioanalytical Assays
por: Gonzalez-Suarez, Alan M., et al.
Publicado: (2022)

Considerations for bioanalytical characterization and batch release of COVID-19 vaccines
por: Sanyal, Gautam, et al.
Publicado: (2021)

An overview of nutritional profiling in foods: Bioanalytical techniques and useful protocols
por: Mondal, Deb Duhita, et al.
Publicado: (2023)

Quantitative microsampling for bioanalytical applications related to the SARS-CoV-2 pandemic: Usefulness, benefits and pitfalls
por: Protti, Michele, et al.
Publicado: (2020)

Immunoassay and other bioanalytical techniques /
Publicado: (2007)

Applications of Lasers in Bioanalytical Chemistry
por: Yeung, Edward S.
Publicado: (1988)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Is there a post-SARS-CoV-2 vaccination dementia?
por: Fiorini, Ana C., et al.
Publicado: (2022)

Review of Chromatographic Bioanalytical Assays for the Quantitative Determination of Marine-Derived Drugs for Cancer Treatment
por: van Andel, Lotte, et al.
Publicado: (2018)

Development and validation of a bioanalytical assay for the measurement of total and unbound teicoplanin in human serum
por: Mouton, J W A, et al.
Publicado: (2023)

Is There a Sars-Cov-2 Silver Lining? Using the Data Beyond the Pandemic
por: Horvath, Keith A.
Publicado: (2022)

EGFET-Based Sensors for Bioanalytical Applications: A Review
por: Pullano, Salvatore Andrea, et al.
Publicado: (2018)

Immunodominant epitopes based serological assay for detecting SARS-CoV-2 exposure: Promises and challenges
por: Quadeer, Ahmed Abdul
Publicado: (2020)

DNA Vaccines for Epidemic Preparedness: SARS-CoV-2 and Beyond
por: Maslow, Joel N., et al.
Publicado: (2023)

Moving beyond the 'pancreatic rest' in severe and critical acute pancreatitis
por: Petrov, Maxim S
Publicado: (2013)

Unanticipated efficacy of SARS-CoV-2 vaccination in older adults
por: Pawelec, Graham, et al.
Publicado: (2021)

Multicomponent vaccines to fight SARS-CoV-2 variants of concern
por: Cassone, Antonio, et al.
Publicado: (2021)

The challenge of emerging SARS-CoV-2 mutants to vaccine development
por: Li, Rong, et al.
Publicado: (2021)

SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
por: Antonopoulou, Tania, et al.
Publicado: (2022)

Questioning the justification for a fourth SARS-CoV-2 vaccine
por: Calderon-Margalit, Ronit, et al.
Publicado: (2022)

Rapid and accurate identification of SARS-CoV-2 variants containing E484 mutation
por: Zhang, Yuan, et al.
Publicado: (2021)

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
por: Muthumani, Kar, et al.
Publicado: (2021)

Vaccine Safety Surveillance Systems: Critical Elements and Lessons Learned in the Development of the US Vaccine Safety Datalink’s Rapid Cycle Analysis Capabilities
por: Davis, Robert L.
Publicado: (2013)

The evolving picture of SARS-CoV-2 and COVID-19 in children: critical knowledge gaps
por: Idele, Priscilla, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lc3j5bb6me4v0aqfqbdgbe5f09